The Rare Bone Disease Working Group: report from the 2016 American Society for Bone and Mineral Research Annual Meeting

Matthew T. Drake; Michael T. Collins; Edward C. Hsiao

doi:10.1016/j.bone.2017.01.021

The Rare Bone Disease Working Group: report from the 2016 American Society for Bone and Mineral Research Annual Meeting

Matthew T. Drake, Michael T. Collins, Edward C. Hsiao

Endocrinology, Diabetes, Metabolism, and Nutrition

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

A working group on rare bone diseases was held in Atlanta, Georgia as part of the 2016 annual meeting of the American Society for Bone and Mineral Research. The meeting was organized by Matthew Drake. Given recent advances in our understanding of fibrodysplasia ossificans progressiva (FOP), the initial portion of the program was devoted to basic, translational, and clinical aspects of FOP. The remainder of the program was divided into updates on an array of rare bone diseases as detailed below. In total, there were more than 120 scientists from academia and industry in attendance.

Original language	English (US)
Pages (from-to)	80-84
Number of pages	5
Journal	Bone
Volume	102
DOIs	https://doi.org/10.1016/j.bone.2017.01.021
State	Published - Sep 2017

Keywords

Fibrous dysplasia
Fibrous dysplasia
Hypophosphatasia
Osteogenesis imperfecta
Osteopetrosis
Rare bone disease
X-linked hypophosphatemia

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Physiology
Histology

Access to Document

10.1016/j.bone.2017.01.021

Fingerprint Dive into the research topics of 'The Rare Bone Disease Working Group: report from the 2016 American Society for Bone and Mineral Research Annual Meeting'. Together they form a unique fingerprint.

Cite this

@article{96d5a949bef74ea1a63f60de2ae769dc,

title = "The Rare Bone Disease Working Group: report from the 2016 American Society for Bone and Mineral Research Annual Meeting",

abstract = "A working group on rare bone diseases was held in Atlanta, Georgia as part of the 2016 annual meeting of the American Society for Bone and Mineral Research. The meeting was organized by Matthew Drake. Given recent advances in our understanding of fibrodysplasia ossificans progressiva (FOP), the initial portion of the program was devoted to basic, translational, and clinical aspects of FOP. The remainder of the program was divided into updates on an array of rare bone diseases as detailed below. In total, there were more than 120 scientists from academia and industry in attendance.",

keywords = "Fibrous dysplasia, Fibrous dysplasia, Hypophosphatasia, Osteogenesis imperfecta, Osteopetrosis, Rare bone disease, X-linked hypophosphatemia",

author = "Drake, {Matthew T.} and Collins, {Michael T.} and Hsiao, {Edward C.}",

year = "2017",

month = sep,

doi = "10.1016/j.bone.2017.01.021",

language = "English (US)",

volume = "102",

pages = "80--84",

journal = "Bone",

issn = "8756-3282",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - The Rare Bone Disease Working Group

T2 - report from the 2016 American Society for Bone and Mineral Research Annual Meeting

AU - Drake, Matthew T.

AU - Collins, Michael T.

AU - Hsiao, Edward C.

PY - 2017/9

Y1 - 2017/9

N2 - A working group on rare bone diseases was held in Atlanta, Georgia as part of the 2016 annual meeting of the American Society for Bone and Mineral Research. The meeting was organized by Matthew Drake. Given recent advances in our understanding of fibrodysplasia ossificans progressiva (FOP), the initial portion of the program was devoted to basic, translational, and clinical aspects of FOP. The remainder of the program was divided into updates on an array of rare bone diseases as detailed below. In total, there were more than 120 scientists from academia and industry in attendance.

AB - A working group on rare bone diseases was held in Atlanta, Georgia as part of the 2016 annual meeting of the American Society for Bone and Mineral Research. The meeting was organized by Matthew Drake. Given recent advances in our understanding of fibrodysplasia ossificans progressiva (FOP), the initial portion of the program was devoted to basic, translational, and clinical aspects of FOP. The remainder of the program was divided into updates on an array of rare bone diseases as detailed below. In total, there were more than 120 scientists from academia and industry in attendance.

KW - Fibrous dysplasia

KW - Hypophosphatasia

KW - Osteogenesis imperfecta

KW - Osteopetrosis

KW - Rare bone disease

KW - X-linked hypophosphatemia

UR - http://www.scopus.com/inward/record.url?scp=85010224348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010224348&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2017.01.021

DO - 10.1016/j.bone.2017.01.021

M3 - Article

C2 - 28115283

AN - SCOPUS:85010224348

VL - 102

SP - 80

EP - 84

JO - Bone

JF - Bone

SN - 8756-3282

ER -